This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Poster presentation
Marijuana use and cervical HPV/neoplasia
1 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
2 Department of Epidemiology & Social Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
3 Maimonides Medical Center and SUNY Downstate, Brooklyn, New York, USA
4 Southern Illinois University School of Medicine, Springfield, Illinois, USA
5 Albert Einstein College of Medicine, Bronx, New York, USA
6 University of Southern California, Los Angeles, California, USA
7 Georgetown University Medical Center, Washington, DC, USA
8 University of California at San Francisco, California, USA
Infectious Agents and Cancer 2009, 4(Suppl 2):P15 doi:10.1186/1750-9378-4-S2-P15
Published: 17 June 2009First paragraph (this article has no abstract)
Recent research suggests that marijuana use may be positively associated with risk of human papillomavirus (HPV)-associated oropharyngeal cancer, and the immunomodulatory effects of cannabinoids are considered a possible mechanism. Were marijuana to have systemic effects on HPV-associated tumorigenesis it would be of major concern, and might be especially harmful in immunologically susceptible populations such as HIV-positive women.